Consistent with this finding, the FOXO1-derived small peptide FO1-6nl inhibits CDK1/2-mediated FOXO1 phosphorylation and prevents prostate cancer proliferation [178]. The gene discussed is FOXO1; the disease is prostate carcinoma.